1monon MSN
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
Failure is a dilemma. Even if your corporate culture is intolerant of failure, leaders know that the result will not be a failure-free company. It will be a culture that hides failures and cannot ...
Asianet Newsable on MSN
SLS stock sees worst day in over a month — but prediction market flashes 83% odds for November AML trial success
Endpoint Area listed Nov. 30 as the expected catalyst timing for Sellas’ Phase 3 GPS trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results